Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta‐analysis

Platelet activation contributes to cardiovascular disease (CVD), the main complication of type 2 diabetes mellitus (T2DM) and pre‐diabetic conditions. Mean platelet volume is an easy‐to‐measure platelet parameter that has been associated with CVD. We sought to assess mean platelet volume, platelet distribution width, and platelet count in T2DM, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and metabolic syndrome.

[1]  J. Bessman.  The relation of megakaryocyte ploidy to platelet volume , 1984, American journal of hematology.

[2]  M. Keleş,et al.  Association of Mean Platelet Volume With The Degree of Retinopathy in Patients with Diabetes Mellitus , 2009 .

[3]  H. Hod,et al.  Increased mean platelet volume is associated with non-responsiveness to clopidogrel , 2014, Thrombosis and Haemostasis.

[4]  C. Patrono,et al.  Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. , 2013, Blood.

[5]  Mei Han,et al.  Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. , 2011, International journal of ophthalmology.

[6]  S. Uchiyama,et al.  Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. , 2002, Thrombosis research.

[7]  A. Abacı,et al.  Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients , 2010, Platelets.

[8]  Yen-Lin Chen,et al.  Association Between Platelet Count and Components of Metabolic Syndrome in Geriatric Taiwanese Males , 2012 .

[9]  P. Sidhu,et al.  Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack , 2004, British journal of haematology.

[10]  E. Coban,et al.  The mean platelet volume in subjects with impaired fasting glucose , 2006, Platelets.

[11]  J. Yudkin,et al.  Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. , 1988, Diabetes research and clinical practice.

[12]  C. Watala,et al.  Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity? , 1999, Platelets.

[13]  M. Vaduganathan,et al.  Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.

[14]  J. González-Porras,et al.  The role of immature platelet fraction in acute coronary syndrome , 2009, Thrombosis and Haemostasis.

[15]  Ş. Bulur,et al.  The relationship between mean platelet volume with metabolic syndrome in obese individuals , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[16]  M. Lishner,et al.  Are platelet volume indices of clinical use? A multidisciplinary review , 2012, Annals of medicine.

[17]  R. Ravindran,et al.  Increased Platelet Cholesterol and Decreased Percentage Volume of Platelets as a Secondary Risk Factor for Coronary Artery Disease , 2008, Pathophysiology of Haemostasis and Thrombosis.

[18]  A. Abacı,et al.  Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. , 2007, Thrombosis research.

[19]  L. Polonski,et al.  Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction. , 2014, Journal of diabetes and its complications.

[20]  G. De Luca,et al.  Diabetes, glucose control and mean platelet volume: a single-centre cohort study. , 2014, Diabetes research and clinical practice.

[21]  B. Egan,et al.  Platelet and White Blood Cell Counts Are Elevated in Patients With the Metabolic Syndrome , 2005, Journal of clinical hypertension.

[22]  E. Grove,et al.  The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes , 2012, Nature Reviews Cardiology.

[23]  C. Patrono,et al.  Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. , 2012, Blood.

[24]  R. Demirtunç,et al.  The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. , 2009, Journal of diabetes and its complications.

[25]  Jin Hwa Kim,et al.  The relationship between mean platelet volume and fasting plasma glucose differs with glucose tolerance status in a Korean general population: Gender differences , 2013, Platelets.

[26]  E. Coban,et al.  The relationship between levels of von Willebrand factor and mean platelet volume in subjects with isolated impaired fasting glucose , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[27]  N. Akhtar,et al.  Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. , 2008, Singapore medical journal.

[28]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[29]  F. Santilli,et al.  The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes , 2012, Journal of thrombosis and haemostasis : JTH.

[30]  K. Kaushansky.  Historical review: megakaryopoiesis and thrombopoiesis. , 2008, Blood.

[31]  Z. Canturk,et al.  The effect of metformin on mean platelet volume in dıabetıc patients , 2013, Platelets.

[32]  N. Lakkis,et al.  Reticulated platelets in acute coronary syndrome: a marker of platelet activity. , 2004, Journal of the American College of Cardiology.

[33]  C Briggs,et al.  Continuing developments with the automated platelet count 1 , 2007, International journal of laboratory hematology.

[34]  G. Davı̀,et al.  In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus , 1999 .

[35]  G. Antonakos,et al.  Platelet Markers Correlate with Glycemic Indices in Diabetic, but Not Diabetic-Myelodysplastic Patients with Normal Platelet Count , 2010, Disease markers.

[36]  G. Davı̀,et al.  In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. , 1999, Circulation.

[37]  I. Hozo,et al.  Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.

[38]  E. Yengil,et al.  Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? , 2014, International journal of clinical and experimental medicine.

[39]  Deepak L. Bhatt,et al.  Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.

[40]  E. Trowbridge,et al.  The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. , 1983, Thrombosis research.

[41]  M. Amini,et al.  Mean platelet volume measurement, EDTA or citrate? , 2006, Hematology.

[42]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[43]  G. Ertas,et al.  A New Parameter Predicting Chronic Total Occlusion of Coronary Arteries , 2014, Angiology.

[44]  A. Tall,et al.  Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. , 2013, Cell metabolism.

[45]  S. Choi,et al.  Immature platelet fraction in diabetes mellitus and metabolic syndrome. , 2013, Thrombosis research.

[46]  S. Grundy.  Pre-diabetes, metabolic syndrome, and cardiovascular risk. , 2012, Journal of the American College of Cardiology.

[47]  D. Mikhailidis,et al.  Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina , 2007, Platelets.

[48]  O. Uysal,et al.  Mean Platelet Volume and Extent and Complexity of Coronary Artery Disease in Diabetic and Nondiabetic Patients With ST Elevation Myocardial Infarction , 2013, Angiology.

[49]  T. Nakayama,et al.  Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects , 2013, Journal of diabetes investigation.

[50]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[51]  G. Tognoni,et al.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[52]  R. Demirtunç,et al.  Effects of Doxazosin and Amlodipine on Mean Platelet Volume and Serum Serotonin Level in Patients with Metabolic Syndrome , 2007, Clinical drug investigation.

[53]  J. Danesh,et al.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.

[54]  K. E. Kim,et al.  Mean platelet volume in the normal state and in various clinical disorders. , 1986, Yonsei medical journal.

[55]  V. Lakshmaiah,et al.  Mean Platelet Volume in Type 2 Diabetes Mellitus , 2012, Journal of laboratory physicians.

[56]  G. Davı̀,et al.  Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.

[57]  D. Mikhailidis,et al.  Mean platelet volume in patients with type 2 diabetes mellitus , 2005, Platelets.

[58]  M. Benn,et al.  High platelet volume and increased risk of myocardial infarction: 39 531 participants from the general population , 2011, Journal of thrombosis and haemostasis : JTH.

[59]  Z. Hekimsoy,et al.  Mean platelet volume in Type 2 diabetic patients. , 2004, Journal of diabetes and its complications.

[60]  J. Hoffmann.  Reticulated platelets: analytical aspects and clinical utility , 2014, Clinical chemistry and laboratory medicine.

[61]  Mario Plebani,et al.  Automated blood cell counts: state of the art. , 2008, American journal of clinical pathology.

[62]  F. Hu,et al.  Exporting diabetes mellitus to Asia: the impact of Western-style fast food. , 2012, Circulation.

[63]  D. Choi,et al.  Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus , 2013, Platelets.

[64]  G. Davı̀,et al.  The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. , 2010, Blood.

[65]  A. Kosar,et al.  Elevated Concentrations of Soluble Adhesion Molecules and Large Platelets in Diabetic Patients: Are They Markers of Vascular Disease and Diabetic Nephropathy? , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[66]  The Emerging Risk Factors Collaboration.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.

[67]  G. Abalı,et al.  Correlation of the Coronary Severity Scores and Mean Platelet Volume in Diabetes Mellitus , 2013, Advances in Therapy.

[68]  I. Ustun,et al.  Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[69]  M. Marescotti,et al.  Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans , 2013, Diabetes Care.

[70]  Binita Shah,et al.  The Relationship Between Diabetes Mellitus , Metabolic Syndrome , and Platelet Activity asMeasured byMean Platelet Volume The National Health and Nutrition Examination Survey , 1999 – 2004 , 2012 .

[71]  Y. Henskens,et al.  Do we need time adjusted mean platelet volume measurements? , 2010, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[72]  M. El Haouari,et al.  Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. , 2008, Blood cells, molecules & diseases.

[73]  E. Coban,et al.  Platelet activation in subjects with impaired glucose tolerance , 2007, Platelets.

[74]  H. Cinemre,et al.  Mean platelet volume is associated with glycaemic control and retinopathy in patients with type 2 diabetes mellitus. , 2013, The West Indian medical journal.

[75]  T. Suehiro,et al.  Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus. , 1994, Journal of atherosclerosis and thrombosis.

[76]  G. De Luca,et al.  Platelet distribution width and the extent of coronary artery disease: Results from a large prospective study , 2010, Platelets.

[77]  H. Hammes,et al.  Erratum: ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (European Heart Journal (2013) 34 (3035-3087) Doi:10.1093/eurheartj/eht108) , 2014 .